2228 Stock Overview
An investment holding company, provides drug discovery and intelligent automation solutions in China, the United States, Europe, South Korea, and Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
XtalPi Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$5.49 |
| 52 Week High | HK$16.20 |
| 52 Week Low | HK$3.05 |
| Beta | 0 |
| 1 Month Change | 35.56% |
| 3 Month Change | -57.11% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -5.34% |
Recent News & Updates
Shareholder Returns
| 2228 | HK Life Sciences | HK Market | |
|---|---|---|---|
| 7D | -7.1% | 0.6% | 1.9% |
| 1Y | n/a | -33.8% | 18.1% |
Return vs Industry: Insufficient data to determine how 2228 performed against the Hong Kong Life Sciences industry.
Return vs Market: Insufficient data to determine how 2228 performed against the Hong Kong Market.
Price Volatility
| 2228 volatility | |
|---|---|
| 2228 Average Weekly Movement | 20.6% |
| Life Sciences Industry Average Movement | 12.1% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in HK Market | 18.7% |
| 10% least volatile stocks in HK Market | 4.0% |
Stable Share Price: 2228's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2228's weekly volatility (21%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 760 | Jian Ma | www.xtalpi.com |
XtalPi Holdings Limited, an investment holding company, provides drug discovery and intelligent automation solutions in China, the United States, Europe, South Korea, and Japan. The company’s drug discovery solutions cover the whole drug discovery and research process, including target validation, hit identification, lead generation, lead optimization, and PCC nomination covering various modalities, which comprise small molecules, antibodies, peptides, ADC, and PROTAC. Its intelligent automation solutions focus on AI- and automation-enabled novel drug and materials discovery and research.
XtalPi Holdings Limited Fundamentals Summary
| 2228 fundamental statistics | |
|---|---|
| Market cap | HK$18.70b |
| Earnings (TTM) | -HK$2.70b |
| Revenue (TTM) | HK$209.76m |
89.2x
P/S Ratio-6.9x
P/E RatioIs 2228 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2228 income statement (TTM) | |
|---|---|
| Revenue | CN¥197.08m |
| Cost of Revenue | CN¥104.80m |
| Gross Profit | CN¥92.29m |
| Other Expenses | CN¥2.63b |
| Earnings | -CN¥2.54b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.75 |
| Gross Margin | 46.83% |
| Net Profit Margin | -1,287.98% |
| Debt/Equity Ratio | 1.6% |
How did 2228 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 04:29 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
XtalPi Holdings Limited is covered by 2 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yu Wu | CMB International Securities Limited |
| Yue-Kwong Lui | Jefferies LLC |